Cargando…
Anti-spike Antibody Status in Pre-vaccinated Healthy Participants and Rheumatoid Arthritis Patients During the Third Wave of COVID-19
Introduction Anti-spike severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies produced after infection with the coronavirus disease of 2019 (COVID-19) will offer protection and prevent re-infection for a few months. Seroprevalence studies measuring the SARS‑CoV-2 immunoglobulin G (...
Autores principales: | Eerike, Madhavi, Sundaramurthy, Raja, Gandham, Ravi, Sakthivadivel, Varatharajan, Amshala, Aravind, Priyadarshini, Rekha, Pyati, Anand K, Patil, Parag |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167490/ https://www.ncbi.nlm.nih.gov/pubmed/37181975 http://dx.doi.org/10.7759/cureus.37316 |
Ejemplares similares
-
Adverse events following remdesivir administration in moderately ill COVID-19 patients - A retrospective analysis
por: Gandham, Ravi, et al.
Publicado: (2022) -
Efficacy and safety of Molnupiravir in COVID-19 patients: a systematic review
por: Mali, Kalpana Ramanna, et al.
Publicado: (2022) -
Is the Gut Microbiota a Neglected Aspect of Gut and Brain Disorders?
por: Balan, Yuvaraj, et al.
Publicado: (2021) -
COVID-19 and Dementia; Hard to Forget Yet Haunting Forgetfulness!
por: Kaliappan, Ariyanachi, et al.
Publicado: (2022) -
Device-Associated Hospital-Acquired Infections: Does Active Surveillance With Bundle Care Offer a Pathway to Minimize Them?
por: Ganesan, Vithiya, et al.
Publicado: (2021)